Delivery Order SPE2DB20D2001-SPE2DB25FPNEA
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Depakote DR 125 mg sprinkle capsules, a neurological medication. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,787.78 and an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a $2,355.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Depakote DR 125 mg sprinkle capsules, a neurological medication, to support military and government healthcare programs. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 4,564,054,632 units of the medication Depakote DR 125 mg Sprinkle Capsules, with a total ceiling value of $2,276.16. The contract is a firm fixed price delivery order with a performance period through March 25, 2024. No set-aside designation was used for this award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.55, is a Firm Fixed Price Delivery Order for the supply of Depakote DR 125 mg sprinkle capsules. The contract has a performance period through March 13, 2025 and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.29 firm fixed-price contract is for the delivery of Depakote DR 125 mg medication sprinkle capsules. It is an open competition contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
- This federal contract award is for the delivery of 100 bottles of Depakote DR 125 mg sprinkle capsules to the Defense Logistics Agency (DLA). The $4,505.10 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,182.63 firm fixed-price delivery order contract is for the supply of Depakote DR 125 mg sprinkle capsules. The ultimate completion date is February 3, 2025. Amerisourcebergen is the prime contractor on this award, which is not designated as a set-aside contract. The company also holds a $999,999,999 Indefinite...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $2,489.13 for the supply of 4,566,120,598 units of Depakote DR 125 mg sprinkle capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,548,337 units of the medication Depakote DR 125 mg sprinkle capsules, with an ultimate completion date of June 16, 2025 and a ceiling value of $2,055.23. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNEADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,358.37 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with a completion deadline of July 21, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a direct procurement of pharmaceutical inventory to support federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion contract vehicle designated SPE2DX and valid through December 2026. The prime IDC enables comprehensive global pharmaceutical support for military healthcare programs worldwide, encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. AmerisourceBergen's role as a primary pharmaceutical vendor through this vehicle demonstrates its established capability to fulfill federal medical procurement requirements and support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/18/25 |